A new trading day began on Tuesday, with Madrigal Pharmaceuticals Inc (NASDAQ: MDGL) stock price down -5.16% from the previous day of trading, before settling in for the closing price of $588.4. MDGL’s price has ranged from $265.00 to $615.00 over the past 52 weeks.
Healthcare Sector giant saw their annual sales slid by -32.06% over the last five years. Meanwhile, its annual earnings per share averaged 50.62%. With a float of $20.63 million, this company’s outstanding shares have now reached $22.70 million.
Madrigal Pharmaceuticals Inc (MDGL) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Madrigal Pharmaceuticals Inc is 9.15%, while institutional ownership is 104.22%. The most recent insider transaction that took place on Dec 10 ’25, was worth 13,694,158. In this transaction Director of this company sold 24,800 shares at a rate of $552.18, taking the stock ownership to the 187,164 shares. Before that another transaction happened on Dec 10 ’25, when Company’s Director sold 18,650 for $552.15, making the entire transaction worth $10,297,573. This insider now owns 461,044 shares in total.
Madrigal Pharmaceuticals Inc (MDGL) Recent Fiscal highlights
In its latest quarterly report, released on 12/31/2024, the company reported earnings of -2.71 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.73 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 50.62% per share during the next fiscal year.
Madrigal Pharmaceuticals Inc (NASDAQ: MDGL) Trading Performance Indicators
Here are Madrigal Pharmaceuticals Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 3.26. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 17.11.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -13.01, a number that is poised to hit -0.91 in the next quarter and is forecasted to reach 1.76 in one year’s time.
Technical Analysis of Madrigal Pharmaceuticals Inc (MDGL)
Analysing the last 5-days average volume posted by the [Madrigal Pharmaceuticals Inc, MDGL], we can find that recorded value of 0.33 million was lower than the volume posted last year of 0.45 million. As of the previous 9 days, the stock’s Stochastic %D was 45.05%.
During the past 100 days, Madrigal Pharmaceuticals Inc’s (MDGL) raw stochastic average was set at 78.39%, which indicates a significant increase from 30.97% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 20.12 in the past 14 days, which was higher than the 19.97 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $540.50, while its 200-day Moving Average is $395.70. Now, the first resistance to watch is $580.19. This is followed by the second major resistance level at $602.37. The third major resistance level sits at $626.25. If the price goes on to break the first support level at $534.14, it is likely to go to the next support level at $510.26. Now, if the price goes above the second support level, the third support stands at $488.08.
Madrigal Pharmaceuticals Inc (NASDAQ: MDGL) Key Stats
With a market capitalization of 12.67 billion, the company has a total of 22,711K Shares Outstanding. Currently, annual sales are 180,130 K while annual income is -465,890 K. The company’s previous quarter sales were 287,270 K while its latest quarter income was -114,190 K.
